NCT06111079View on ClinicalTrials.gov

Aspirin Discontinuation in High-Risk Pregnant Women of Preeclampsia

PHASE3RecruitingINTERVENTIONAL
Enrollment

1,800

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

December 30, 2024

Study Completion Date

December 31, 2024

Conditions
PreeclampsiaPerinatal Haemorrhage
Interventions
DRUG

aspirin discontinuation

Initiation of aspirin 100mg qn from 12 to 16 weeks of gestation, discontinuing aspirin at 28 weeks of gestation according to randomization at 24-27+6 weeks of gestation.

DRUG

aspirin continuation

Initiation of aspirin 100mg qn from 12 to 16 weeks of gestation, continuing aspirin until 36 weeks of gestation according to randomization at 24-27+6 weeks of gestation.

Trial Locations (1)

510150

RECRUITING

FANG HE, Guangzhou

All Listed Sponsors
lead

FANG HE

OTHER